Infection and Hyperinfection with Strongyloides stercoralis: Clinical Presentation, Etiology of Disease, and Treatment Options

Nicolas Barros, Martin Montes

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Human strongyloidiasis is a neglected global parasitic disease that affects large populations, especially in poorer regions of the world. Improved diagnostic tools, including serology and molecular tests, are demonstrating that the prevalence of infection is far higher than previously thought. Most complications arise as a consequence of delayed diagnosis, primarily due to physicians not considering this potentially lethal parasitic infection. The likelihood of developing mild chronic strongyloidiasis or hyperinfection syndrome depends on the status of the host defenses. The critical host responses controlling Strongyloides stercoralis in animal models include eosinophils, neutrophils, and antibodies. Corticosteroid treatment and human T-lymphotropic virus (HTLV)-1 infection predispose to hyperinfection in humans, but how these result in hyperinfection is poorly defined. Improved diagnostic tests and molecular epidemiology are highlighting the underappreciated burden of disease, which could be addressed with mass chemotherapy with proven effective drugs like ivermectin.

Original languageEnglish (US)
Pages (from-to)223-228
Number of pages6
JournalCurrent Tropical Medicine Reports
Volume1
Issue number4
DOIs
StatePublished - Dec 1 2014

Fingerprint

Strongyloidiasis
Strongyloides stercoralis
Parasitic Diseases
Ivermectin
Human T-lymphotropic virus 1
Molecular Epidemiology
Delayed Diagnosis
Virus Diseases
Serology
Infection
Routine Diagnostic Tests
Eosinophils
Adrenal Cortex Hormones
Neutrophils
Animal Models
Physicians
Drug Therapy
Antibodies
Therapeutics
Pharmaceutical Preparations

Keywords

  • Etiology
  • Hyperinfection
  • Infection
  • Parasitic infection
  • Strongyloides
  • Tropical medicine

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Infection and Hyperinfection with Strongyloides stercoralis : Clinical Presentation, Etiology of Disease, and Treatment Options. / Barros, Nicolas; Montes, Martin.

In: Current Tropical Medicine Reports, Vol. 1, No. 4, 01.12.2014, p. 223-228.

Research output: Contribution to journalReview article

@article{c40cb1c48a45482987de93a2d6368bc6,
title = "Infection and Hyperinfection with Strongyloides stercoralis: Clinical Presentation, Etiology of Disease, and Treatment Options",
abstract = "Human strongyloidiasis is a neglected global parasitic disease that affects large populations, especially in poorer regions of the world. Improved diagnostic tools, including serology and molecular tests, are demonstrating that the prevalence of infection is far higher than previously thought. Most complications arise as a consequence of delayed diagnosis, primarily due to physicians not considering this potentially lethal parasitic infection. The likelihood of developing mild chronic strongyloidiasis or hyperinfection syndrome depends on the status of the host defenses. The critical host responses controlling Strongyloides stercoralis in animal models include eosinophils, neutrophils, and antibodies. Corticosteroid treatment and human T-lymphotropic virus (HTLV)-1 infection predispose to hyperinfection in humans, but how these result in hyperinfection is poorly defined. Improved diagnostic tests and molecular epidemiology are highlighting the underappreciated burden of disease, which could be addressed with mass chemotherapy with proven effective drugs like ivermectin.",
keywords = "Etiology, Hyperinfection, Infection, Parasitic infection, Strongyloides, Tropical medicine",
author = "Nicolas Barros and Martin Montes",
year = "2014",
month = "12",
day = "1",
doi = "10.1007/s40475-014-0030-y",
language = "English (US)",
volume = "1",
pages = "223--228",
journal = "Current Tropical Medicine Reports",
issn = "2196-3045",
publisher = "Springer International Publishing AG",
number = "4",

}

TY - JOUR

T1 - Infection and Hyperinfection with Strongyloides stercoralis

T2 - Clinical Presentation, Etiology of Disease, and Treatment Options

AU - Barros, Nicolas

AU - Montes, Martin

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Human strongyloidiasis is a neglected global parasitic disease that affects large populations, especially in poorer regions of the world. Improved diagnostic tools, including serology and molecular tests, are demonstrating that the prevalence of infection is far higher than previously thought. Most complications arise as a consequence of delayed diagnosis, primarily due to physicians not considering this potentially lethal parasitic infection. The likelihood of developing mild chronic strongyloidiasis or hyperinfection syndrome depends on the status of the host defenses. The critical host responses controlling Strongyloides stercoralis in animal models include eosinophils, neutrophils, and antibodies. Corticosteroid treatment and human T-lymphotropic virus (HTLV)-1 infection predispose to hyperinfection in humans, but how these result in hyperinfection is poorly defined. Improved diagnostic tests and molecular epidemiology are highlighting the underappreciated burden of disease, which could be addressed with mass chemotherapy with proven effective drugs like ivermectin.

AB - Human strongyloidiasis is a neglected global parasitic disease that affects large populations, especially in poorer regions of the world. Improved diagnostic tools, including serology and molecular tests, are demonstrating that the prevalence of infection is far higher than previously thought. Most complications arise as a consequence of delayed diagnosis, primarily due to physicians not considering this potentially lethal parasitic infection. The likelihood of developing mild chronic strongyloidiasis or hyperinfection syndrome depends on the status of the host defenses. The critical host responses controlling Strongyloides stercoralis in animal models include eosinophils, neutrophils, and antibodies. Corticosteroid treatment and human T-lymphotropic virus (HTLV)-1 infection predispose to hyperinfection in humans, but how these result in hyperinfection is poorly defined. Improved diagnostic tests and molecular epidemiology are highlighting the underappreciated burden of disease, which could be addressed with mass chemotherapy with proven effective drugs like ivermectin.

KW - Etiology

KW - Hyperinfection

KW - Infection

KW - Parasitic infection

KW - Strongyloides

KW - Tropical medicine

UR - http://www.scopus.com/inward/record.url?scp=85048573621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048573621&partnerID=8YFLogxK

U2 - 10.1007/s40475-014-0030-y

DO - 10.1007/s40475-014-0030-y

M3 - Review article

AN - SCOPUS:85048573621

VL - 1

SP - 223

EP - 228

JO - Current Tropical Medicine Reports

JF - Current Tropical Medicine Reports

SN - 2196-3045

IS - 4

ER -